Prednicarbate

BRAND NAMES

• Dermatop (most widely known brand)

MECHANISM OF ACTION

Prednicarbate is a topical corticosteroid that works by binding to intracellular glucocorticoid receptors in skin cells. After binding, the drug–receptor complex moves into the nucleus and alters gene transcription. This leads to increased production of anti-inflammatory proteins and suppression of pro-inflammatory genes. It inhibits the release of inflammatory mediators such as prostaglandins and leukotrienes by blocking phospholipase A2 activity and reducing arachidonic acid formation. Additionally, it decreases the activity and migration of immune cells like lymphocytes and macrophages to the site of inflammation. These actions result in reduced redness, swelling, itching, and other signs of skin inflammation.

PHARMACODYNAMICS

Prednicarbate produces its pharmacological effects through activation of glucocorticoid receptors in the skin, leading to regulation of gene expression involved in inflammation and immune responses. It exerts strong anti-inflammatory, antipruritic (anti-itch), and vasoconstrictive actions. By suppressing the synthesis and release of inflammatory mediators such as cytokines, prostaglandins, and leukotrienes, it reduces redness, swelling, and irritation in affected skin areas. It also inhibits the migration and activity of inflammatory cells like macrophages and lymphocytes, thereby decreasing immune-mediated skin reactions. Overall, its pharmacodynamic effects result in rapid relief of inflammatory skin conditions with a relatively favorable safety profile compared to more potent corticosteroids.

ADMINISTRATION

Prednicarbate is administered topically as a cream, ointment, or sometimes lotion, depending on the formulation. It is applied in a thin layer directly to the affected skin area, usually once or twice daily as prescribed by a healthcare professional. The skin should be clean and dry before application, and the medication should be gently rubbed in until absorbed. It is important to avoid applying it to large surface areas, broken skin, or under occlusive dressings unless specifically directed, as this may increase absorption. Contact with eyes, mouth, and mucous membranes should be avoided. Treatment duration is generally short-term, and long-term use should be monitored to prevent local side effects such as skin thinning.

DOSAGE AND STRENGTH

Prednicarbate is available as a topical corticosteroid mainly in the form of cream and ointment. The most common strength is 0.1% (1 mg/g) formulation. It is usually applied in a thin layer to the affected skin areas once or twice daily, depending on the severity of the condition and the doctor’s advice. The dose is not measured in tablets or systemic units but in the amount applied to the skin, often guided by the “fingertip unit” method. Treatment is typically used for short durations, and prolonged use is avoided to reduce the risk of local side effects such as skin thinning or irritation.

DRUG INTERACTIONS

Prednicarbate has minimal clinically significant drug interactions due to its low systemic absorption when used topically. However, interactions may occur if it is applied over large areas, used for prolonged periods, or under occlusive dressings, which can increase systemic absorption. In such cases, it may enhance the effects of other corticosteroids or drugs that suppress the hypothalamic–pituitary–adrenal (HPA) axis, increasing the risk of systemic corticosteroid effects. Concurrent use with other topical irritants or strong dermatologic agents (such as retinoids or harsh exfoliants) may increase skin irritation. Although rare, drugs that strongly inhibit or induce hepatic enzymes may theoretically affect corticosteroid metabolism if significant systemic absorption occurs.

CONTRAINDICATIONS

Prednicarbate is contraindicated in patients with known hypersensitivity to prednicarbate or any component of the formulation. It should not be used in untreated bacterial, viral (such as herpes simplex, varicella), or fungal skin infections, as corticosteroids can worsen or mask these conditions. It is also contraindicated in acne vulgaris, rosacea, and perioral dermatitis, where topical steroids may aggravate symptoms.

SIDE EFFECTS

• Skin irritation or burning sensation at application site 

• Itching (pruritus) 

• Dry skin 

• Redness (erythema) 

• Local skin thinning (atrophy) with prolonged use 

• Stretch marks (striae) 

• Acneiform eruptions (steroid acne) 

• Folliculitis (inflammation of hair follicles) 

• Hypopigmentation or skin color changes 

• Telangiectasia (visible small blood vessels) 

• Delayed wound healing (rare) 

• Secondary skin infections (bacterial, fungal, or viral) due to immune suppression 

• Rare: allergic contact dermatitis 

• Very rare (with excessive use): systemic corticosteroid effects like adrenal suppression

OVER DOSE 

Overdose of prednicarbate is uncommon due to its topical use, but excessive application, prolonged use, or use over large skin areas can lead to increased absorption. This may result in both local and systemic corticosteroid effects. Locally, overdose can cause marked skin thinning (atrophy), severe irritation, stretch marks (striae), and delayed wound healing.

TOXICITY

Toxicity from prednicarbate is rare because it is a topical corticosteroid with low systemic absorption when used correctly. However, toxicity may occur with excessive application, prolonged use, use over large body surface areas, or under occlusive dressings. Local toxicity includes severe skin thinning (atrophy), striae (stretch marks), telangiectasia, pigmentation changes, and increased risk of secondary skin infections due to immune suppression.